Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1970 Mar;1(3):288–292. doi: 10.1128/iai.1.3.288-292.1970

Immunosuppression by Murine Sarcoma Virus (Moloney)

S P Chan a,1, W A Hook a, W Turner a, M A Chirigos a
PMCID: PMC415894  PMID: 16557730

Abstract

Infection of mice with the murine sarcoma virus (Moloney) markedly suppressed the humoral antibody response to sheep erythrocyte antigen injected 10 days after infection, when tumor size was maximal, and on day 26, when primary tumors had partially regressed. Humoral antibody response was also inhibited when antigen was injected at the time secondary tumors and metastases were evident. No significant suppression of humoral antibody was seen when mice were injected with sheep erythrocyte antigen 5 days after virus infection. Inhibition of the cellular immune response of murine sarcoma virus (Moloney)-infected mice, as measured by the increased survival time of skin grafts, was also determined. Mice that were infected 5 days prior to grafting demonstrated prolonged survival of grafts, suggesting a suppression of cellular immunity. These mice had a graft survival time 14 days greater than noninfected controls. No significant prolongation of graft survival was seen in mice grafted at the times of maximum primary tumor growth, of primary tumor regression, or when secondary tumors had appeared.

Full text

PDF
288

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C. Studies on delayed hypersensitivity in Hodgkin's disease. J Clin Invest. 1962 Nov;41:1964–1970. doi: 10.1172/JCI104654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERENBAUM M. C. EFFECTS OF CARCINOGENS ON IMMUNE PROCESSES. Br Med Bull. 1964 May;20:159–164. doi: 10.1093/oxfordjournals.bmb.a070311. [DOI] [PubMed] [Google Scholar]
  3. BURNET M. IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS. Br Med Bull. 1964 May;20:154–158. doi: 10.1093/oxfordjournals.bmb.a070310. [DOI] [PubMed] [Google Scholar]
  4. Blumenschein G. R., Moloney J. B. Quantitative dose-response relationships of murine sarcoma virus (Moloney) in BALB/c mice. J Natl Cancer Inst. 1969 Jan;42(1):123–133. [PubMed] [Google Scholar]
  5. Borella L. The suppressive effect of Rauscher leukemia virus on the secondary antibody response of spleen cells cultured in cell-impermeable diffusion chambers. J Immunol. 1969 Aug;103(2):185–195. [PubMed] [Google Scholar]
  6. Ceglowski W. S., Friedman H. Immunosuppression by leukemia viruses. 3. Adoptive transfer of antibody-forming cells to Friend disease virus-infected mice. J Immunol. 1969 Sep;103(3):460–466. [PubMed] [Google Scholar]
  7. Ceglowski W. S., Friedman H. Immunosuppression by leukemia viruses. I. Effect of Friend disease virus on cellular and humoral hemolysin responses of mice to a primary immunization with sheep erythrocytes. J Immunol. 1968 Sep;101(3):594–604. [PubMed] [Google Scholar]
  8. Ceglowski W. S., Friedman H. Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J Natl Cancer Inst. 1968 May;40(5):983–995. [PubMed] [Google Scholar]
  9. Cremer N. E., Taylor D. O., Hagens S. J. Antibody formation, latency and leukemia: infection with Moloney virus. J Immunol. 1966 Mar;96(3):495–508. [PubMed] [Google Scholar]
  10. Cure S. F., Cremer N. E. Decreased rate of synthesis of immunoglobulin (IgG) in rats infected with moloney leukemia virus. J Immunol. 1969 Jun;102(6):1345–1353. [PubMed] [Google Scholar]
  11. DENT P. B., PETERSON R. D., GOOD R. A. A DEFECT IN CELLULAR IMMUNITY DURING THE INCUBATION PERIOD OF PASSAGE A LEUKEMIA IN C3H MICE. Proc Soc Exp Biol Med. 1965 Jul;119:869–871. doi: 10.3181/00379727-119-30323. [DOI] [PubMed] [Google Scholar]
  12. GELLER W. A study of antibody formation in patients with malignant lymphomas. J Lab Clin Med. 1953 Aug;42(2):232–237. [PubMed] [Google Scholar]
  13. GREENBERG J., NADEL E. M., COATNEY G. R. Differences in survival of several inbred strains of mice and their hybrids infected with Plasmodium berghei. J Infect Dis. 1954 Jul-Aug;95(1):114–116. doi: 10.1093/infdis/95.1.114. [DOI] [PubMed] [Google Scholar]
  14. Hook W. A., Chirigos M. A., Chan S. P. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum. Cancer Res. 1969 May;29(5):1008–1012. [PubMed] [Google Scholar]
  15. LARSON D. L., TOMLINSON L. J. Quantitative antibody studies in man. III. Antibody response in leukemia and other malignant lymphomata. J Clin Invest. 1953 Apr;32(4):317–321. doi: 10.1172/JCI102741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. O'Connor T. E., Fischinger P. J. Titration patterns of a murine sarcoma-leukemia virus complex: evidence for existence of competent sarcoma virions. Science. 1968 Jan 19;159(3812):325–329. doi: 10.1126/science.159.3812.325. [DOI] [PubMed] [Google Scholar]
  17. Odaka T., Ishi H., Yamaura K., Yamamoto T. Inhibitory effect of Friend leukemia virus infection on the antibody formation to sheep erythrocytes in mice. Jpn J Exp Med. 1966 Jun;36(3):277–290. [PubMed] [Google Scholar]
  18. PETERSON R. D., HENDRICKSON R., GOOD R. A. REDUCED ANTIBODY FORMING CAPACITY DURING THE INCUBATION PERIOD OF PASSAGE A LEUKEMIA IN C3H MICE. Proc Soc Exp Biol Med. 1963 Nov;114:517–520. doi: 10.3181/00379727-114-28720. [DOI] [PubMed] [Google Scholar]
  20. Siegel B. V., Morton J. I. Serum agglutinin levels to sheep red blood cells in mice infected with Rauscher virus. Proc Soc Exp Biol Med. 1966 Nov;123(2):467–470. doi: 10.3181/00379727-123-31516. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES